For the one million people diagnosed with Parkinson's disease in the United States1, Medtronic plc (NYSE:MDT), a global ...

In the 2024 financial year, Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin at 36.1%. The sales growth is driven by both Food & Health Biosolutions and Planetary Health ...

ViCentra B.V., the company behind Kaleido, one of the world's smallest, lightest, and most precise insulin patch pump and automated insulin delivery (AID) system, today announced the appointment of ...

LEO Pharma delivered another year of strong progress in 2024, with both sales growth and adjusted EBITDA margin ahead of the initial outlook for the year, putting the company on track to meet its ...

Hikma Pharmaceuticals PLC (‘Hikma’ or ‘Group’), the multinational pharmaceutical company, today reports its audited results for the year ended 31 December 2024. Riad Mishlawi, Chief Executive Officer ...

Eli Lilly and Company (NYSE: LLY) announced the launch of 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, available for $499 with the new Zepbound Self Pay Journey Program.1 Lilly also ...

Genmab A/S (Nasdaq: GMAB) will increase its share capital by 10,058 shares as a consequence of the exercise of employee warrants. The increase is effected without any preemption rights for the ...

Today, at the 7th Patient Centricity & Collaboration World Congress in London, The Bloc unveiled In.Pazienti, a global community that connects, supports, and amplifies the voices of patients through ...

The China cell culture media bags market is set for robust expansion, with projections indicating it will reach USD 198.1 million by 2025 and grow at a 4.7% CAGR, exceeding USD 313.6 million by ...

The Canada axillary hyperhidrosis market is poised for significant expansion, with market value expected to grow from USD 65.4 million in 2025 to USD 120.5 million by 2035, reflecting a 6.3% CAGR.The ...

February 16, 2025 Clinion, a leading innovator in AI-powered clinical trial technology, will unveil Agentic AI at ACDM 2025, marking a significant leap in the evolution of AI-driven clinical trial ...

The China aquaculture vaccines market is set to achieve a valuation of USD 31.4 million by 2025, with an anticipated CAGR of 8.1% from 2025 to 2035. As the world’s largest aquaculture producer, China ...